{"schema_version":"secwatch.filing_event.v1","accession":"0001779128-24-000012","form_type":"8-K","ticker":"SRTA","cik":"0001779128","company_name":"Strata Critical Medical, Inc.","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.493593+00:00","generated_at":"2026-06-04T23:10:57.891299+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Blade Q4 revenue up 24.5% to $47.5M; guides for 2024 Adj. EBITDA profitability","bullets":["Q4 revenue $47.5M (+24.5% YoY); full year revenue $225.2M (+54.1%).","Net loss widened to $(33.9)M in Q4 from $(15.4)M; Adj. EBITDA improved to $(5.2)M from $(8.0)M.","Full year 2023 Adj. EBITDA $(16.6)M; guides for 2024 Adj. EBITDA profitability and 2025 double-digit millions.","Announced pending purchase of eight jet aircraft to support Medical growth; new organ placement service launched.","Medical segment Adj. EBITDA positive $2.5M in Q4, up 57.8% YoY; Passenger Adj. EBITDA loss improved to $(2.6)M."],"urls":{"canonical":"https://secwatch.observer/filing/0001779128-24-000012","json":"https://secwatch.observer/filing/0001779128-24-000012.json","markdown":"https://secwatch.observer/filing/0001779128-24-000012.md","text":"https://secwatch.observer/filing/0001779128-24-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779128/000177912824000012/0001779128-24-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779128/000177912824000012/blde-20240312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:10:57.891299+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8ed3beda4dafeec9a6b7789d8a06b9e1998951c3","claim":"Strata Critical Medical, Inc. reported the fourth quarter ended December 31, 2023 results: revenue $47,478, net income $(33,941). Guidance initiated.","evidence_excerpt":"2023. GAAP FINANCIAL RESULTS (in thousands except percentages, unaudited) Three Months Ended December 31, Year Ended December 31, 2023 2022 % Change 2023 2022 % Change Revenue $ 47,478 $ 38,135 24.5 % $ 225,180 $ 146,120 54.1 % Cost of revenue 38,468 33,160 16.0 % 183,058 123,845 47.8 % Software development 988 1,622 (39.1) % 4,627 5,545 (16.6) % General and","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779128/000177912824000012/0001779128-24-000012-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$47,478"},{"label":"Net income","value":"$(33,941)"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}